Similarities and dissimilarities of COVID-19 and other coronavirus diseases
TS Fung, DX Liu - Annual review of microbiology, 2021 - annualreviews.org
In less than two decades, three deadly zoonotic coronaviruses, severe acute respiratory
syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS …
syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS …
History, phytochemistry, experimental pharmacology and clinical uses of honey: A comprehensive review with special reference to Unani medicine
S Nikhat, M Fazil - Journal of ethnopharmacology, 2022 - Elsevier
Ethnopharmacological relevance Honey is one of the most popular functional foods,
speculated to be in use since the advent of human civilization. Its health-protective activity is …
speculated to be in use since the advent of human civilization. Its health-protective activity is …
Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities
B Diego-Martin, B González, M Vazquez-Vilar… - Frontiers in plant …, 2020 - frontiersin.org
The current CoVid-19 crisis is revealing the strengths and the weaknesses of the world's
capacity to respond to a global health crisis. A critical weakness has resulted from the …
capacity to respond to a global health crisis. A critical weakness has resulted from the …
Convalescent plasma for infectious diseases: historical framework and use in COVID-19
JG Ripoll, N van Helmond, JW Senefeld… - Clinical Microbiology …, 2021 - Elsevier
Convalescent plasma has emerged as a promising therapeutic agent for patients with
coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is …
coronavirus disease 2019 (COVID-19), has received emergency use authorization, and is …
[HTML][HTML] Convalescent plasma for the prevention and treatment of COVID-19: a systematic review and quantitative analysis
Background: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2,
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
Preclinical assessment of IgY antibodies against recombinant SARS-CoV-2 RBD protein for prophylaxis and post-infection treatment of COVID-19
A Agurto-Arteaga, A Poma-Acevedo… - Frontiers in …, 2022 - frontiersin.org
Within the framework of the current COVID-19 pandemic, there is a race against time to find
therapies for the outbreak to be controlled. Since vaccines are still tedious to develop and …
therapies for the outbreak to be controlled. Since vaccines are still tedious to develop and …
Convalescent plasma therapy for management of COVID-19: Perspectives and deployment in the current global pandemic
The world is striving against the severe crisis of the COVID-19 pandemic. Healthcare
professionals are struggling to treat their patients based on nonspecific therapies. Amidst …
professionals are struggling to treat their patients based on nonspecific therapies. Amidst …
A mass cytometry method pairing T cell receptor and differentiation state analysis
J Garcia Castillo, R DeBarge, A Mende… - Nature …, 2024 - nature.com
T cell antigen receptor (TCR) recognition followed by clonal expansion is a fundamental
feature of adaptive immune responses. Here, we present a mass cytometric (CyTOF) …
feature of adaptive immune responses. Here, we present a mass cytometric (CyTOF) …
Evolution and immunopathology of chikungunya virus informs therapeutic development
F Henderson Sousa… - Disease Models & …, 2023 - journals.biologists.com
Chikungunya virus (CHIKV), a mosquito-borne alphavirus, is an emerging global threat
identified in more than 60 countries across continents. The risk of CHIKV transmission is …
identified in more than 60 countries across continents. The risk of CHIKV transmission is …
SARS-CoV-2 spike protein extrapolation for COVID diagnosis and vaccine development
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to coronavirus disease
2019 (COVID-19) pandemic affecting nearly 71.2 million humans in more than 191 …
2019 (COVID-19) pandemic affecting nearly 71.2 million humans in more than 191 …